4/A: Heron Therapeutics Director Receives Stock Options and Restricted Stock Units
SEC Form 4/A
Director Sharmila Dissanaike acquired stock options and restricted stock units in Heron Therapeutics, Inc.
Summary
- On January 31, 2025, Sharmila Dissanaike, a director of Heron Therapeutics, Inc., acquired 17,950 shares of common stock as restricted stock units and stock options for 35,900 shares.
- The restricted stock units vest in full on January 31, 2026, and each unit represents a contingent right to receive one share of common stock.
- The stock options vest in 12 equal monthly installments starting one month after the grant date and have an exercise price of $1.70.
- Following these transactions, Dissanaike directly owns 87,180 shares of Heron Therapeutics common stock and 35,900 stock options.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it reports a standard transaction of stock options and restricted stock units granted to a director. It's a routine event and doesn't inherently indicate positive or negative performance.
Positives
- The grant of restricted stock units and stock options to a director aligns their interests with those of the shareholders.
- The vesting schedule of the stock options encourages continued service and contribution to the company's success.
Industry Context
Stock options and restricted stock units are common forms of executive compensation in the biotechnology industry, aligning management's interests with shareholder value creation.
Comparison to Industry Standards
- Stock option grants are a standard component of compensation packages for directors in publicly traded companies, particularly in the biotech sector.
- Vesting schedules, such as the 12-month monthly vesting for the options, are typical to incentivize long-term commitment.
- The specific number of shares and option grants would need to be compared to peer companies of similar market capitalization and stage of development to assess relative generosity.
Stakeholder Impact
- The grant of stock options and restricted stock units can positively impact shareholders by aligning the director's interests with the company's long-term success.
- Employees may view this as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 01/31/2025 | Date of transaction: Acquisition of restricted stock units and stock options. |
| 01/31/2026 | Vesting date for the restricted stock units. |
| 01/31/2035 | Expiration date for the stock options. |
| 02/03/2025 | Date of original filing. |
| 02/04/2025 | Date of signature on the amended form. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.